Scientific Reference

Melanotan II (MT-II)

Evidence profile: Human Phase 1 evidence

Melanotan II (MT-II) is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) that activates multiple melanocortin receptors (MC1R, MC3R, MC4R, MC5R). It was originally developed as a sunless tanning agent but is also associated with effects on sexual arousal and appetite regulation due to broader receptor activity. Unlike Melanotan I, MT-II is non-selective across melanocortin receptors, resulting in both pigmentation effects and systemic neurological and metabolic effects. It produces rapid tanning, often without UV exposure, though minimal UV exposure enhances results.

Published Research

  • Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review

    Habbema L et al. · International journal of dermatology · 2017 · Review

    PMID 28266027 — View on PubMed
  • Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study

    Dorr RT et al. · Life sciences · 1996 · Clinical

    PMID 8637402 — View on PubMed
  • Melanotan II: a possible cause of renal infarction: review of the literature and case report

    Peters B et al. · CEN case reports · 2020 · Review

    PMID 31953620 — View on PubMed
  • Melanotan-associated melanoma

    Paurobally D et al. · The British journal of dermatology · 2011 · Preclinical

    PMID 21564053 — View on PubMed